2-[8-[(1R,3R)-3-hydroxycyclohexyl]-2-[(1-methylsulfonyl-4-piperidyl)amino]-7-oxo-pyrido[2,3-d]pyrimidin-6-yl]acetamide

ID: ALA4800105

PubChem CID: 134253173

Max Phase: Preclinical

Molecular Formula: C21H30N6O5S

Molecular Weight: 478.58

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCC(Nc2ncc3cc(CC(N)=O)c(=O)n([C@@H]4CCC[C@@H](O)C4)c3n2)CC1

Standard InChI:  InChI=1S/C21H30N6O5S/c1-33(31,32)26-7-5-15(6-8-26)24-21-23-12-14-9-13(10-18(22)29)20(30)27(19(14)25-21)16-3-2-4-17(28)11-16/h9,12,15-17,28H,2-8,10-11H2,1H3,(H2,22,29)(H,23,24,25)/t16-,17-/m1/s1

Standard InChI Key:  MMHOKKKPDYDUDS-IAGOWNOFSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   12.1217  -18.0525    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5344  -18.7624    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.9428  -18.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0741  -19.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0730  -19.9987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7810  -20.4077    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7792  -18.7703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4879  -19.1756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4867  -20.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1968  -20.4121    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9126  -20.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9138  -19.1776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1992  -18.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6192  -20.4134    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3650  -20.4068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6576  -19.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6576  -19.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9543  -18.7717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2439  -19.1763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2413  -19.9944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9491  -20.4080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8285  -19.1698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6225  -18.7708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3292  -19.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0379  -18.7742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3272  -19.9983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1964  -21.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4857  -21.6315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4815  -22.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1862  -22.8595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8969  -22.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9028  -21.6344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6002  -22.8607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 11 14  2  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19  2  1  0
  2 22  1  0
 12 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 27 10  1  1
 31 33  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4800105

    ---

Associated Targets(Human)

CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 478.58Molecular Weight (Monoisotopic): 478.1998AlogP: 0.13#Rotatable Bonds: 6
Polar Surface Area: 160.51Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.66CX LogP: -1.91CX LogD: -1.91
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -0.92

References

1. Abdel-Magid AF..  (2021)  Potential of Cyclin-Dependent Kinase Inhibitors as Cancer Therapy.,  12  (2): [PMID:33603963] [10.1021/acsmedchemlett.1c00017]

Source